JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Česko-slovenská pediatrie, 2026 (vol. 81), Suppl.

Glucose metabolism disorders in children and adolescents with obesity

Lenka Veselá, Zdeněk Šumník, Irena Aldhoon Hainerová

Čes-slov Pediat 2026, 81(88):5-12 | DOI: 10.55095/CSPediatrie2026/019  

Obesity in children and adolescents is frequently associated with disturbances in glucose metabolism, such as insulin resistance, prediabetes, or type 2 diabetes. These conditions pose an increased risk of early-onset metabolic and cardiovascular complications. Prediabetes represents an intermediate state between normoglycemia and overt diabetes, with the highest risk of progression to type 2 diabetes observed in adolescents with s evere obesity. A combination of marked insulin resistance and rapid deterioration of pancreatic β-cell function characterizes the pathophysiology of type 2 diabetes at this age. This article summarizes current knowledge...

Diagnostic and therapeutic recommendations for dyslipidemia in children and adolescents with obesity

Irena Aldhoon Hainerová, Pavel Ješina, Michal Vrablík

Čes-slov Pediat 2026, 81(88):13-19 | DOI: 10.55095/CSPediatrie2026/021  

Dyslipidemia represents a significant risk factor for the development of atherosclerotic cardiovascular disease in children and adolescents with obesity. Atherosclerotic changes begin in childhood, making early diagnosis and intervention crucial. The prevalence of dyslipidemia is several times higher in children with overweight or obesity compared with those of normal body weight. The etiology of dyslipidemia can be primary, genetically determined-such as familial hypercholesterolemia or combined hyperlipidemias-or secondary, associated with obesity, insulin resistance, diabetes, or other conditions. In children with obesity, mixed etiology is common,...

Hypertension in children with obesity: a practical guide to diagnosis and treatment

Bohuslav Procházka, Tomáš Seeman

Čes-slov Pediat 2026, 81(88):20-27 | DOI: 10.55095/CSPediatrie2026/022  

The article emphasizes the importance of early recognition of arterial hypertension in children with obesity and highlights the need for targeted therapeutic interventions. Obesity in children, frequently associated with hypertension, is a major risk factor for the development of cardiovascular disease, with clinical manifestations that may appear as early as the third or fourth decade of life. In combination with other metabolic complications, it may result in substantial organ damage and an unfavourable long-term prognosis. The article also provides practical recommendations for the diagnosis and management of hypertension in children and adolescents...

Hyperuricemia in children and adolescents with obesity - a review of current knowledge

Jan Boženský, Eva Havránková, Magdalena Pencová, Pavel Ješina

Čes-slov Pediat 2026, 81(88):28-32 | DOI: 10.55095/CSPediatrie2026/006  

Hyperuricemia is a common, yet often overlooked, metabolic comorbidity of childhood obesity. Although gout is rare in children, chronic elevation of uric acid can have similar systemic consequences as in adults - including the development of arterial hypertension, insulin resistance, and kidney damage. This article summarizes current knowledge about its prevalence, pathophysiology, consequences, diagnosis and treatment in children and adolescents with obesity.

Hepatic steatosis and steatohepatitis as complications of childhood obesity

Eliška Hloušková, Jana Šťastná, Petr Jabandžiev

Čes-slov Pediat 2026, 81(88):33-38 | DOI: 10.55095/CSPediatrie2026/023  

The most common gastrointestinal complication of childhood obesity is fatty liver, steatosis or steatohepatitis. Due to the rising prevalence of obesity, steatotic liver disease has become the most common liver disease of childhood. The etiology is complex and not always dependent on obesity of the patient. Consequently, the nomenclature has undergone changes in recent years. Instead of the former term Non-alcoholic fatty liver disease, it is now recommended to use the term Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). The term Metabolic Dysfunction-Associated Steatohepatitis (MASH) has been coined for inflammatory liver disease...

Obstructive sleep apnea in children with obesity

Jana Křenek Malíková, Lucie Kešnerová, Katalin Štěrbová, Alena Tesfayeová, Václav Koucký

Čes-slov Pediat 2026, 81(88):39-46 | DOI: 10.55095/CSPediatrie2026/020  

Pediatric obstructive sleep apnea (OSA) is a common and potentially serious sleep disorder characterized by recurrent episodes of apnea and hypopnea resulting from intermittent partial or complete upper airway obstruction. These events are associated with hypoxemia, hypercapnia, sleep fragmentation, and heightened sympathetic nervous system activation. The prevalence of pediatric OSA is estimated at 1-5%, with substantially higher rates observed in children with obesity. Obesity represents a key pathophysiological contributor to OSA in childhood. Its mechanistic pathways include upper airway soft-tissue fat deposition, altered hormonal regulation,...

Diagnostic and therapeutic recommendations for polyendocrine metabolic ovarian syndrome in girls with obesity

Renata Pilcová

Čes-slov Pediat 2026, 81(88):47-53 | DOI: 10.55095/CSPediatrie2026/007  

Polyendocrine metabolic ovarian syndrome (PMOS) is one of the most common endocrine disorders in women of reproductive age and can manifest already during adolescence. PMOS is characterized by hyperandrogenism (clinical and/or biochemical) and ovarian dysfunction. However, in adolescent girls, the diagnosis is often made in the presence of overlap with normal pubertal changes (e.g., menstrual irregularities or acne). Overweight and obesity in girls increase the risk of metabolic complications of PMOS and may worsen its symptoms. If left untreated, especially in the context of obesity, PMOS can lead to fertility issues, metabolic complications of obesity,...